|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| C07K 16/12 | (2006.01) | ||
| C07K 14/21 | (2006.01) |
| (11) | Number of the document | 3498292 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18211544.4 |
| Date of filing the European patent application | 2015-02-20 | |
| (97) | Date of publication of the European application | 2019-06-19 |
| (45) | Date of publication and mention of the grant of the patent | 2021-10-20 |
| (46) | Date of publication of the claims translation | 2021-11-25 |
| (30) | Number | Date | Country code |
| 201461943909 P | 2014-02-24 | US | |
| 201461946932 P | 2014-03-30 | US | |
| 201461946937 P | 2014-03-03 | US |
| (72) |
BLAIS, Normand , BE
CASTADO, Cindy , BE
CHOMEZ, Patrick , BE
DEWERCHIN, Marianne , BE
|
| (73) |
GlaxoSmithKline Biologicals SA ,
Rue de l'Institut, 89, 1330 Rixensart,
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | UspA2 baltymo konstruktai ir jų panaudojimas |
| USPA2 PROTEIN CONSTRUCTS AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2024-01-23 | 10 | 231.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2025-02-20 |